New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: A personal appraisal of their use in practice

被引：8

作者：

Callen, JP ^{[1
]}

机构：

[1] Univ Louisville, Sch Med, Div Dermatol, Louisville, KY 40202 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2003年 / 49卷 / 02期

关键词：

D O I：

10.1067/S0190-9622(03)01149-6

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：351 / 356

页数：6

共 19 条

[1]

ABELSON R, 2003, NY TIMES 0126

[2] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].

Baert, F ;

Noman, M ;

Vermeire, S ;

Van Assche, G ;

D'Haens, G ;

Carbonez, A ;

Rutgeerts, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608

[3]

Callis KP, 2002, J INVEST DERMATOL, V119, P244

[4] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

[5] Infliximab for the treatment of severe pustular psoriasis [J].

Elewski, BE .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (05) :796-797

[6]

Galaria NA, 2000, J RHEUMATOL, V27, P2041

[7]

GORDON KB, 2002, PSORIASIS FORUM, V8, P1

[8]

GOTTLIEB A, 2002, 60 ANN M AM AC DERM

[9] Psoriasis as a model for T-cell-mediated disease - Immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody [J].

Gottlieb, AB ;

Krueger, JG ;

Wittkowski, K ;

Dedrick, R ;

Walicke, PA ;

Garovoy, M .

ARCHIVES OF DERMATOLOGY, 2002, 138 (05) :591-600

[10] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

← 1 2 →